Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
26 Sep 2024
Dr Pardo chairs questions with Prof Giaccone on his presentation on immunotherapy in NSCLC at the Future Horizons in Lung Cancer meeting.
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
ESMO 2024: Latest in EGFR mutated NSCLC
Biomarkers, predictive and prognostic factors of resistance to immunotherapy
Uncommon genetic aberrations NTRK, RET, NRG
ASCO 2024: Lung cancer highlights
ASCO 2024: Lung cancer roundup
ASCO 2024: Advances in NSCLC
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Updates on lung cancer from WCLC and ESMO 2023